Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

New methods for antinuclear antibody testing: does it cut costs and corners without jeopardizing clinical reliability?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wallace DJ and Metzger AL (1992) Positive LE preps and negative ANA in brothers with SLE: is there still a role for the LE cell prep? A literature review. J Rheumatol 19: 497

    CAS  PubMed  Google Scholar 

  2. Solomon DH et al. (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47: 434–444

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel J Wallace.

Ethics declarations

Competing interests

The Wallace Rheumatic Studies Center was a participating center in a clinical trial sponsored by Bio-Rad Laboratories, Hercules, CA, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallace, D. New methods for antinuclear antibody testing: does it cut costs and corners without jeopardizing clinical reliability?. Nat Rev Rheumatol 2, 410–411 (2006). https://doi.org/10.1038/ncprheum0253

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0253

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing